XML 51 R40.htm IDEA: XBRL DOCUMENT v3.26.1

Note 16 - Share-based Payments (Tables)

3 Months Ended

Mar. 31, 2026

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Three Months Ended March 31, 2026								Three Months Ended March 31, 2025
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			961,376			$	39.65				1,122,700			$	45.86
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited			(3,975	)			22.01				(18,228	)			40.76
Expired			(3,721	)			49.72				(60,509	)			60.30
Outstanding, end of period			953,680				39.69				1,043,963				45.11
Options exercisable, end of period			562,467			$	51.44				557,558			$	57.68

		Three Months Ended March 31, 2026								Three Months Ended March 31, 2025
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			15,305,714			$	1.34				15,887,997			$	1.28
Granted			15,500				1.81				226,000				1.78
Exercised			-				-				-				-
Forfeited			(6,250	)			1.27				(72,063	)			1.45
Expired			(22,812	)			1.36				(301,132	)			1.27
Outstanding, end of period			15,292,152				1.34				15,740,802				1.32
Options exercisable, end of period			13,765,473			$	1.30				11,656,385			$	1.28

		Three Months Ended March 31, 2026								Three Months Ended March 31, 2025
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			4,646,012			$	6.00				5,959,660			$	6.00
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited			(71,925	)			6.00				(91,658	)			6.00
Expired			(36,756	)			6.00				(930,891	)			6.00
Outstanding, end of period			4,537,331				6.00				4,937,111				6.00
Options exercisable, end of period			4,490,653			$	6.00				3,797,940			$	6.00

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$16.47 - $19.93			146,262			$	18.96				5.9			$	3				23,875			$	19.27				4.4			$	3
$20.25 - $28.37			369,564				22.70				5.1				-				131,531				23.30				4.8				-
$30.70 - $30.74			5,000				30.74				3.7				-				3,750				30.74				3.7				-
$40.04 - $48.00			127,465				42.00				3.2				-				97,922				42.02				3.2				-
$51.82 - $59.98			13,350				55.53				0.8				-				13,350				55.53				0.8				-
$60.01 - $68.41			142,416				60.94				0.7				-				142,416				60.94				0.7				-
$70.13 - $79.51			140,623				78.45				1.8				-				140,623				78.45				1.8				-
$80.61 - $82.07			9,000				80.61				2.5				-				9,000				80.61				2.5				-
			953,680			$	39.69				3.7			$	3				562,467			$	51.44				2.6			$	3

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $1.81			15,292,152			$	1.34				3.6			$	7,186				13,765,473			$	1.30				3.6			$	7,075
			15,292,152			$	1.34				3.6			$	7,186				13,765,473			$	1.30				3.6			$	7,075

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $6.00			4,537,331			$	6.00				4.0			$	-				4,490,653			$	6.00				4.0			$	-
			4,537,331			$	6.00				4.0			$	-				4,490,653			$	6.00				4.0			$	-

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Three Months Ended March 31,
		2026				2025
Company options		$	953			$	1,102
Wavelo options			148				442
Ting options			11				31
Capitalized stock-based compensation			(18	)			(70	)
Total stock-based compensation expense		$	1,094			$	1,505

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration